Receiving the COVID-19 vaccine and booster reduces preeclampsia risk by nearly 60% among pregnant patients with preexisting morbidities.
The updated 2024-2025 mRNA COVID-19 vaccine was linked to moderate protection against severe COVID-19 outcomes, including hospitalizations.
An early Moderna COVID‑19 trial has resurfaced six years on, amid ongoing debate over vaccine risks, guidance and public ...
The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever and general malaise ...
Researchers used five prospective cohorts from the US and China to identify circulating gut microbiota-related metabolites ...
Mycobacterial diseases, including tuberculosis (TB), leprosy, and non-tuberculous mycobacterial (NTM) infections, continue to impose a substantial global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results